Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial, Contraception, vol.49, issue.1, pp.56-72, 1994. ,
DOI : 10.1016/0010-7824(94)90109-0
La contraception en France : vers un nouveau modèle contraceptif ?, p.511, 2014. ,
Différenciation entre les deux systèmes de diffusion intra-utérins (SIU) existants Jaydess® et Mirena®, 2014. ,
Complications and Continuation of Intrauterine Device Use Among Commercially Insured Teenagers, Obstetrics & Gynecology, vol.121, issue.5, pp.951-958, 2013. ,
DOI : 10.1097/AOG.0b013e31828b63a0
Dispositifs intra-utérins. Consensus canadien sur la contraception, J Obstet Gynaecol Can, vol.26, issue.3, pp.289-296, 2004. ,
Contraception par dispositif intra-ut??rin, EMC - Gyn??cologie, vol.1, issue.1, 2001. ,
DOI : 10.1016/S0246-1064(01)00051-2
http://www.cespharm.fr/fr/Preventionsante/L-education-pour-la-sante/Role-du-pharmacien ,
Sonographic Appearances of Chinese Intrauterine Devices, Journal of Ultrasound in Medicine, vol.29, issue.7, pp.1093-1101, 2010. ,
DOI : 10.7863/jum.2010.29.7.1093
Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report, Journal of Family Planning and Reproductive Health Care, vol.28, issue.2, pp.73-77, 2002. ,
DOI : 10.1783/147118902101196225
Suivi et conseils apr??s infections g??nitales hautes, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.41, issue.8, pp.922-929, 2012. ,
DOI : 10.1016/j.jgyn.2012.09.023
Levonorgestrel-releasing (20 mug/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives, BJOG: An International Journal of Obstetrics and Gynaecology, vol.25, issue.10, pp.1218-1225, 2000. ,
DOI : 10.1016/0010-7824(89)90014-0
Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, Epidemiology, vol.11, pp.1974-1990, 2000. ,
A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena, Fertility and Sterility, vol.97, issue.3, pp.616-622, 2012. ,
DOI : 10.1016/j.fertnstert.2011.12.003
Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use (intervention review), 2011. ,
Mise au point sur la contraception intra-ut??rine en 15??questions-r??ponses, Gyn??cologie Obst??trique & Fertilit??, vol.40, issue.1, pp.37-42, 2012. ,
DOI : 10.1016/j.gyobfe.2011.07.022
Contraception: your questions answered, 2013. ,
Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?, Contraception, vol.67, issue.1, pp.53-59, 2003. ,
DOI : 10.1016/S0010-7824(02)00417-1
Contraceptifs oraux estroprogestatifs : préférez les « pilules » de 1 e ou 2 e génération, 2012. ,
Efficacité des méthodes contraceptives, 2013. ,
Méthodes contraceptives : focus sur les méthodes les plus efficaces disponibles, 2013. ,
Comparative Contraceptive Effectiveness of Levonorgestrel-Releasing and Copper Intrauterine Devices, Obstetrical & Gynecological Survey, vol.70, issue.5, 2015. ,
DOI : 10.1097/01.ogx.0000466339.43485.6e
Biological Evaluation of the Copper/Low-density Polyethylene Nanocomposite Intrauterine Device, PLoS ONE, vol.95, issue.9, p.74128, 2013. ,
DOI : 10.1371/journal.pone.0074128.t002
Pain from copper intrauterine device insertion: Randomized trial of prophylactic ibuprofen, American Journal of Obstetrics and Gynecology, vol.195, issue.5, pp.1272-1277, 2006. ,
DOI : 10.1016/j.ajog.2006.08.022
Noncontraceptive Health Benefits of Intrauterine Devices: A Systematic Review, Obstetrical and Gynecological Survey, vol.57, issue.2, pp.120-128, 2002. ,
DOI : 10.1097/00006254-200202000-00024
Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women, N, 2001. ,
Dispositif intra-utérin (stérilet) http ,
DIU au cuivre : pourquoi choisir une contraception nonhormonale? Gynécologie Obstétrique & Fertilité, pp.2-5, 2010. ,
The effect of low-dose 3-keto-desogestrel added to a copper-releasing intrauterine contraceptive device on menstrual blood loss: A double-blind, dose-finding, placebo-controlled study, American Journal of Obstetrics and Gynecology, vol.182, issue.3, pp.575-581, 2000. ,
DOI : 10.1067/mob.2000.104805
Effect of the levonorgestrel-releasing intrauterine system on the uterine artery pulsatility index in postmenopausal hormone replacement therapy, Ultrasound in Obstetrics and Gynecology, vol.10, issue.5, pp.350-355, 1997. ,
DOI : 10.1046/j.1469-0705.1997.10050350.x
The effect of a levonorgestrel-releasing intrauterine system on uterine artery blood flow, hormone concentrations and ovarian cyst formation in fertile women, Human Reproduction, vol.13, issue.12, pp.3379-3383, 1998. ,
DOI : 10.1093/humrep/13.12.3379
Actinomyces in cervical smears of women using the intrauterine device in Singapore, Contraception, vol.73, issue.4, pp.352-355, 2006. ,
DOI : 10.1016/j.contraception.2005.09.005
Contraception locale, méthodes naturelles et contraceptions difficiles Gynécologie pour le praticien, pp.441-451, 2012. ,
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, BMJ, vol.344, 2001. ,
Pelvic actinomycosis: A review and preliminary look at prevalence, American Journal of Obstetrics and Gynecology, vol.180, issue.2, 1999. ,
DOI : 10.1016/S0002-9378(99)70198-5
Progestin-only contraceptives: effects on weight, 2011. ,
Inhibition of DNA synthesis in isolated human endometrial cells by a levonorgestrel-releasing intrauterine device, Anal. Quant. Cytol. Histol, vol.21, pp.409-412, 1999. ,
Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?, Human Reproduction, vol.12, issue.12, pp.2671-2675, 1997. ,
DOI : 10.1093/humrep/12.12.2671
Actinomycose pelvienne??: est-ce pr??visible???, Gyn??cologie Obst??trique & Fertilit??, vol.38, issue.5, pp.307-312, 2010. ,
DOI : 10.1016/j.gyobfe.2010.03.006
Un recours moindre à l'IVG, mais plus souvent répété. Populations & Sociétés, n°518, 2015. ,
Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010, Fertility and Sterility, vol.100, issue.2, pp.451-459, 2000. ,
DOI : 10.1016/j.fertnstert.2013.04.002
IUD use in France: women's and physician's perspectives, Contraception, vol.89, issue.1, pp.9-16, 2014. ,
DOI : 10.1016/j.contraception.2013.10.003
Frequency of discontinuation of contraceptive use: results from a French population-based cohort, Human Reproduction, vol.24, issue.6, pp.1387-1392, 2009. ,
DOI : 10.1093/humrep/dep027
URL : https://hal.archives-ouvertes.fr/inserm-00464855
Un st??rilet qui fait de plus en plus mal??? o?? il ne suffit pas d???en voir les fils pour exclure une malposition??!, Gyn??cologie Obst??trique & Fertilit??, vol.42, issue.4, pp.261-264 ,
DOI : 10.1016/j.gyobfe.2011.08.019
ORIGINAL RESEARCH???WOMEN's SEXUAL DYSFUNCTION: Impact of Oral Contraceptives on Sex Hormone???Binding Globulin and Androgen Levels: A Retrospective Study in Women with Sexual Dysfunction, The Journal of Sexual Medicine, vol.3, issue.1, pp.104-117, 2006. ,
DOI : 10.1111/j.1743-6109.2005.00198.x
Contraceptions non hormonales, La revue du praticien, vol.58, pp.29-39, 2008. ,
State-of-the-art of non-hormonal methods of contraception, 2010. ,
Prolonged intrauterine contraception: A seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS, Contraception, vol.44, issue.5, pp.473-480, 1991. ,
DOI : 10.1016/0010-7824(91)90149-A
Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices, American Journal of Obstetrics and Gynecology, vol.166, issue.4, pp.1208-1213, 1992. ,
DOI : 10.1016/S0002-9378(11)90607-3
The evidence is in. Why are IUDs still out? : family physicians' perceptions of risk and indications, Can Fam Physician, vol.54, pp.560-566, 2008. ,
Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study, Contraception, vol.69, issue.5, pp.407-412, 2004. ,
DOI : 10.1016/j.contraception.2003.11.008
Risk factors for IUD failure: results of a large multicentre case-control study, Human Reproduction, vol.21, issue.10, pp.2612-2616, 2006. ,
DOI : 10.1093/humrep/del208
Dispositif intra-ut??rin et nulliparit??, Gyn??cologie Obst??trique & Fertilit??, vol.42, issue.6, pp.432-437, 2014. ,
DOI : 10.1016/j.gyobfe.2014.04.003
Use of the levonorgestrel-releasing intrauterine system in breast cancer patients, Fertility and Sterility, vol.90, issue.1, pp.17-22, 2008. ,
DOI : 10.1016/j.fertnstert.2007.05.033
Fertility after stopping use of intrauterine contraceptive device., BMJ, vol.286, issue.6359, 1983. ,
DOI : 10.1136/bmj.286.6359.106
Les interruptions volontaires de grossesse en 2013, Études et Résultats, 2015. ,
Prevalence of Sexual Dysfunction and Impact of Contraception in Female German Medical Students, The Journal of Sexual Medicine, vol.7, issue.6, pp.2139-2148, 2010. ,
DOI : 10.1111/j.1743-6109.2010.01742.x
A random control study of indomethacincontaining MYCu intrauterine contraceptive device for 60 months, Zhonghua Yi Xue Za Zhi, vol.93, pp.496-499, 2013. ,
A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: A four-year study, American Journal of Obstetrics and Gynecology, vol.160, issue.2, pp.391-396, 1989. ,
DOI : 10.1016/0002-9378(89)90455-9
La contraception du futur, 2003. ,
Les dispositifs intra-utérins (DIU ou « stérilets »). Editions « J'ai Lu ». Contraceptions mode d'emploi, pp.269-333, 2007. ,